Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV.
Marylee W TailorElias B ChahineDavid E KorenElizabeth M ShermanPublished in: The Annals of pharmacotherapy (2023)
Lenacapavir is an effective and well-tolerated option for HTE patients which is a valuable addition to the arsenal of ARVs.